In 2025, Rx/reimbursement adult incontinence in Latvia demonstrated solid performance, with volume reaching 25.6 million units and a value of EUR9.1 million. Growth accelerated in 2025, with volume increasing by 3% and value up by 5%, after a period of stagnation in 2024. Market growth outpaced the overall consumer expenditure trend, highlighting that demand for these products is resilient even in a challenging economic context.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Latvia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Latvia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Rx/Reimbursement adult incontinence in Latvia report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Rx/Reimbursement adult incontinence in Latvia?
- Which are the leading brands in Rx/Reimbursement adult incontinence in Latvia?
- How are products distributed in Rx/Reimbursement adult incontinence in Latvia?
- How is the rise of e-commerce changing the retail and competitive landscape?
- How has COVID-19 impacted demand? Where have sales increased due to stockpiling amidst national lockdown?
- How have enforced home seclusion and social distancing measures following COVID-19 changed usage patterns for Rx/Reimbursement adult incontinence products?
- Where is future growth expected to be most dynamic?
- How important will sustainability and recycling be in generating future growth?
Rx/Reimbursement Adult Incontinence in Latvia - Category analysis
Key Data Insights
Tena Men Expands Design Options as Convenience Drives Uptake
Tena Men Expands Design Options as Convenience Drives Uptake
Consumer Demand for Tailored Design Reshapes Product Innovation
Tailored Product Launches Meet Rising Demand for Discretion
Manufacturers Introduce Discreet Formats as Stigma Recedes
State-Backed Reimbursement Channels Sustain Stable Product Uptake
Tissue and Hygiene in Latvia - Industry Overview
Rimi and Maxima Ignite Price Wars, Reshaping Affordability for Shoppers
Key Data Insights
Rimi and Maxima Ignite Price Wars, Reshaping Affordability for Shoppers
Adult Incontinence Surges as an Ageing Population Drives Sustained Demand
Convenience Drives Underlying Demand in Tissue and Hygiene
Retailers Expand Private Label While Brands Defend Premium Share
Older Consumers Boost Adult Incontinence as Population Ages
Discounters and E-Commerce Reshape Shopper Habits and Pricing Power
Rimi and Maxima Drive Consolidation through Private Label Expansion
Maxima and Rimi Drive Value through Promotions and Assortment
Online Arms of Major Chains Capture E-Commerce Momentum with Delivery and Deals
Drogas Extends Private Label Reach as Specialist Stores Gain Traction
Country Reports Disclaimer
Rx/Reimbursement adult incontinence
To qualify for reimbursement, typically a note from a physician is required (a “prescription”) indicating that the patient is in need of incontinence supplies. Depending on the local system in place, supplies are then either shipped directly to consumer home by a designated service or a consumer has to pick up products at a pharmacy. Please be advised that services and routes to consumers can vary even within the same country and vary by state/region. Some countries provide reimbursement through income tax deductions. If this is the case in your market, we EXCLUDE this type of reimbursement from our Rx/Reimbursement coverage as it would be impossible to track. Additionally, consumers would have already purchased the products in retail before claiming tax deductions, and as such the products have already been counted as retail sales. The same logic applies to institutional sales. If a nursing home purchased adult incontinence products from a distributor/manufacturer for distribution to its patients/residents, these products would be included as AFH adult incontinence in our coverage, even though sometimes patients might claim healthcare deductions for costs of stay at a nursing home.
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!